Hypertrophic Cardiomyopathy (HCM)

What is Hypertrophic Cardiomyopathy (HCM)?

Hypertrophic Cardiomyopathy (HCM) is a genetic heart condition characterized by abnormal thickening of the heart muscle. This thickening of the heart muscle most commonly occurs in the left ventricle, which is the heart’s main pumping chamber.

As the heart muscle thickens, the heart’s ability to pump blood can be affected, and some patients may develop serious heart rhythm disorders. Although hypertrophic cardiomyopathy can occur at any age, it is most frequently diagnosed in young adults and middle-aged individuals.

What Causes Hypertrophic Cardiomyopathy?

Hypertrophic cardiomyopathy is predominantly an inherited condition. It develops due to changes in the genes that form the structure of the heart muscle.

Therefore:

  • Family members may have a history of a similar condition.
  • First-degree relatives may need to be screened.
  • The condition can be passed down from generation to generation.

In some individuals, it may also appear without any family history.

What Are the Symptoms of Hypertrophic Cardiomyopathy?

Some patients may experience no symptoms for many years. The condition may be detected incidentally during a routine examination.

However, in patients who do experience symptoms, the following may occur:

  • Shortness of breath
  • Chest pain
  • Palpitations
  • Dizziness
  • Fainting or feeling lightheaded
  • Getting tired easily during exertion
  • Decreased exercise capacity

The severity of symptoms can vary from person to person.

Why Can Hypertrophic Cardiomyopathy Be Dangerous?

Excessive thickening of the heart muscle can narrow the heart’s outflow tract in some patients and make it harder for blood to leave the heart.

Additionally:

  • Serious rhythm disorders
  • Heart failure
  • Sudden cardiac death

complications such as these may develop.

However, with regular monitoring and appropriate treatment, these risks can be significantly reduced.

How Is Hypertrophic Cardiomyopathy Diagnosed?

Electrocardiogram (ECG)

Evaluates the electrical activity of the heart and can reveal certain abnormalities.

Echocardiogram (Echo)

One of the most important methods in diagnosis.

With an echocardiogram:

  • The thickness of the heart muscle is measured.
  • The pumping function of the heart is evaluated.
  • Outflow tract obstruction is investigated.

Cardiac Magnetic Resonance (Cardiac MRI)

Provides detailed imaging of the heart muscle.

It can offer valuable information for risk assessment and treatment planning.

Holter Rhythm Monitor

Helps detect rhythm disorders that may occur during daily life.

Exercise Stress Tests

Can be used to evaluate symptoms and perform risk analysis.

Genetic Testing

May be performed in certain patients and family members to support the diagnosis.

What Are Obstructive and Non-Obstrüktif Hypertrophic Cardiomyopathy?

Obstructive Hypertrophic Cardiomyopathy

The thickened heart muscle causes narrowing in the heart’s outflow tract.

In this case:

  • Shortness of breath
  • Chest pain
  • Fainting

may be more common.

Non-Obstructive Hypertrophic Cardiomyopathy

There is thickening of the heart muscle, but no significant narrowing in the outflow tract.

How Is Hypertrophic Cardiomyopathy Treated?

Treatment is planned based on the patient’s symptoms, risk status, and disease severity.

Medication

It is the first treatment choice for many patients.

Medications can:

  • Reduce the workload of the heart.
  • Control palpitations.
  • Decrease chest pain.
  • Provide relief from shortness of breath.

Septal Reduction Therapies

Can be applied to patients with severe narrowing in the heart’s outflow tract.

These methods can be implemented as:

  • Surgical myectomy
  • Alcohol septal ablation

.

ICD (Implantable Cardioverter Defibrillator)

May be recommended for patients found to be at high risk for sudden cardiac death.

An ICD:

  • Continuously monitors the heart rhythm.
  • Treats life-threatening rhythm disorders.
  • Can reduce the risk of sudden death.

What Is Alcohol Septal Ablation?

It is performed in certain patients to shrink the thickened muscle tissue that narrows the heart’s outflow tract.

During the procedure:

  • A special catheter is advanced through a coronary artery.
  • A controlled amount of alcohol is injected into the vessel supplying the thickened area.
  • Part of the heart muscle is shrunk to widen the outflow tract.

This method can yield effective results in selected patients.

Is There a Risk of Sudden Death in Hypertrophic Cardiomyopathy?

Most patients can lead a healthy life for many years.

However, the risk of sudden cardiac death may increase in some patients.

In risk assessment, factors such as:

  • History of fainting
  • Family history of sudden death
  • Serious rhythm disorders
  • Degree of heart muscle thickness
  • Cardiac MRI findings

are taken into account.

If the risk is found to be high, ICD therapy may be recommended.

Living with Hypertrophic Cardiomyopathy

Many patients can maintain a normal life with appropriate treatment and regular follow-up.

Recommendations:

  • Cardiology check-ups should not be neglected.
  • Medications prescribed by the doctor must be taken regularly.
  • Exercise plans should be made according to medical advice.
  • Family members should participate in screening programs.
  • A doctor should be consulted if palpitations, fainting, or shortness of breath develop.

Frequently Asked Questions

Is hypertrophic cardiomyopathy hereditary?

Yes. The condition is most often genetically transmitted.

Does hypertrophic cardiomyopathy cure completely?

Currently, there is no treatment that completely eliminates the disease. However, with appropriate treatment, symptoms can be controlled, and the risk of complications can be reduced.

Can people with hypertrophic cardiomyopathy play sports?

The decision to exercise must be made based on the patient’s risk status. Therefore, any sports plan must be created under doctor’s recommendations.

Does every patient need an ICD implanted?

No. An ICD is only recommended for selected patients who are at high risk for sudden death.

Conclusion

Hypertrophic Cardiomyopathy is a heart condition that arises from the thickening of the heart muscle and is predominantly genetic. While it causes no symptoms in some individuals, it can lead to shortness of breath, chest pain, palpitations, and rhythm disorders in others. Thanks to regular monitoring, appropriate medical therapy, and interventional methods when necessary, the majority of patients can lead an active and high-quality life. Early diagnosis and risk assessment are of great importance in preventing potential complications.

This content is intended for general informational purposes only. Diagnostic and treatment decisions must be individually evaluated by a specialist cardiologist.

TR|EN